- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Economic woes affect attendance
A big drop in exhibitor attendance led to an overall 5% decline in the number ofpeople who attended the 2008 RSNA meeting. Audited totals released by the RSNAafter the end of sessions on Dec. 5 indicate that 58,795 people attended the weeklongscientific assembly and meeting.
A big drop in exhibitor attendance led to an overall 5% decline in the number of people who attended the 2008 RSNA meeting. Audited totals released by the RSNA after the end of sessions on Dec. 5 indicate that 58,795 people attended the weeklong scientific assembly and meeting.
Vendor attendance declined 12% to 24,683. According to the RSNA, 726 technical exhibits occupied 516,100 square feet, down 4% from the 2007 total.
Many exhibitors expressed concerned during the week about the growing international economic crisis prompted by a historic collapse of global financial markets in October. The U.S. Bureau of Labor Statistics announced during the conference week that U.S. employers had cut 533,000 jobs in November, the biggest one-month cut since December 1974. Medical imaging equipment sales declines have dogged the industry at least since the initiation of Medicare rate cuts for high-tech outpatient imaging procedures in January 2007.
Despite a modest increase in preregistration numbers, professional attendance fell 1% to 27,586. Many attendees mentioned that they did not notice a change in the overall traffic across the Lake Shore Drive bridge from the North and South buildings to the Lakeside Center. Attendance by guests rose 7% to 6526.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
